← FDA Drug Approvals (Drugs@FDA)

RIFAMPIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2026-06-29

Drug application

FDA Application #

ANDA219918

Application type

Abbreviated New Drug Application (Generic)

Brand name

RIFAMPIN

Generic name

RIFAMPIN

Active ingredients

RIFAMPIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

NOVITIUM PHARMA

Manufacturer

ANI Pharmaceuticals, Inc.

First approval

2026-06-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown